Seres Therapeutics, Inc.·4

Jan 29, 6:51 PM ET

COOK DAVID N 4

4 · Seres Therapeutics, Inc. · Filed Jan 29, 2019

Insider Transaction Report

Form 4
Period: 2019-01-26
COOK DAVID N
See Remarks
Transactions
  • Exercise/Conversion

    COMMON STOCK

    2019-01-26+7,500147,435 total
  • Exercise/Conversion

    RESTRICTED STOCK UNITS

    2019-01-267,50012,500 total
    Common Stock (7,500 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F2]These restricted stock units have vested and settled or will vest and settle as to 20% of the restricted stock units on January 26, 2018, 30% on January 26, 2019, and 50% on January 26, 2020.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION